Effect of Yukgunja-tang on patients with functional dyspepsia classified by 3-Dimensional Facial Shape Diagnostic System
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0001920
- Lead Sponsor
- Dong-Eui University Oriental Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 96
1. Individuals between the ages of 19 and 75 years
2. Individuals who meet the Rome III functional dyspepsia criteria
3. Individuals who check more than 40 points on the visual analogue scale (0-100) for dyspeptic symptoms
4. Individuals who voluntarily agree with a study protocol and sign a written informed consent
1. Individuals who have peptic ulcer or gastroesophageal reflux disease
2. Individuals who have obvious signs of irritable bowel syndrome
3. Individuals who have alarm symptoms (weight loss, black or tar stool, or dysphagia)
4. Individuals who have serious structural disease (malignant tumors, disease of heart, lung, liver or kidney) or mental illness
5. Individuals who have had surgery related with the gastrointestinal tract, except for appendectomy more than six months ago
6. Individuals who have other structural disease related with the gastrointestinal tract (e.g., cholangitis, pancreatitis)
7. Individuals who have had maxillofacial surgery or facial bone contouring surgery
8. Individuals who are taking drugs which might affect the gastrointestinal tract (Proton-pump inhibitors(PPIs), H2 antagonists, Antacids, gastrointestinal motility promoters, antibiotics, Nonsteroidal anti-inflammatory drugs(NSAIDs), muscle relaxants, antidepressants, stabilizer); a minimum wash-out period of one week is required before participating in the trial
9. Individuals who are pregnant or breastfeeding
10. Individuals who have a problem of malabsorption or maldigestion
11. Individuals who are human immunodeficiency virus(HIV) positive
12. Individuals who have difficulty in attending the trial (e.g., severe mental or psychological abnormality, dementia, drug addiction, time constraint, severe disorder in vision or hearing, outpatient treatment impossibility, illiteracy)
13. Individuals who have taken any other Investigational drug within 3 months
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method